Home Your basket
• Tuberculous otomastoiditi...
   Price 5.50 €
• Cholesteatoma and osteora...
   Price 14.00 €
• Dynamic palatography: Dia...
   Price 12.50 €
• Relevance of Choukroun’s ...
   Price 8.50 €
• International Conference ...
   Price 5.50 €
• Value of the preservation...
   Price 14.00 €
• The domes crossover: A ne...
   Price 10.50 €
• Stingy speakers....
   Price 5.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• Laryngeal tuberculosis: A...
   Price 5.50 €
• Osteointegrated cranio-fa...
   Price 10.50 €
• Rhinolithiasis: Review ab...
   Price 5.50 €
• A new tongue plate for us...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• Cranial fasciitis of chil...
   Price 8.50 €
• Autologous bone pate in m...
   Price 10.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• Myringoplasties for anter...
   Price 10.50 €
• Validity of cervical ausc...
   Price 12.00 €
• Vestibular disorders in B...
   Price 14.00 €
• The input of autogenous g...
   Price 10.50 €
• Role of positron emission...
   Price 15.00 €
• A clinical respiratory ev...
   Price 10.50 €
• Assessment of migraine re...
   Price 8.50 €
• Quality of life before an...
   Price 10.50 €
• Osteoblastoma of the eth...
   Price 10.50 €
• Different clinical approa...
   Price 5.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Cine-MRI contribution to ...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Evaluation of the presenc...
   Price 12.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Orbital apex syndrome fol...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Interest of the cervical ...
   Price 10.50 €
• Voice after supracricoid ...
   Price 10.50 €

Total Order 357.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE